China Shineway Pharmaceutical Group Limited announced that Mr. Liu Tiejun ("Mr. Liu") has been appointed as executive director of the Company with effect from 1 November 2022. Mr. Liu, aged 48, joined the Group in 1999 and was appointed as vice president of Shineway Pharmaceutical Group Limited ("Shineway Pharmaceutical") (an indirect wholly-owned subsidiary of the Company) on 16 May 2013. Mr. Liu is qualified as a senior engineer and is a certified pharmacist.

He graduated from Hebei Medical University in 1999 with a bachelor's degree in pharmacy. Mr. Liu is a member of the China Association of Chinese Medicine (Chinese Medicine Branch) and a deputy director of the National and Local United Engineering Laboratory for the Development Technology of New Chinese Medicine Injection. He has received an award of "Model Worker of Hebei Province" by the People's Government of Hebei Province.

Mr. Liu is currently the rotating president and the legal representative of Shineway Pharmaceutical, being responsible for overseeing the Group's production technology management with more than 20 years of experience. The Board also announced that Mr. Chen Zhong ("Mr. Chen") has tendered his resignation as an executive director of the Company with effect from 1 November 2022, due to his intention to devote more time to pursue his personal interests.